Recent Updates in Monitoring and Sequencing Treatment in Chronic Lymphocytic Leukemia.
- Published in:
- Oncology (08909091), 2023, v. 37, n. 3, p. 150
- By:
- Publication type:
- Article
Works matching IS 08909091 AND DT 2023 AND VI 37 AND IP 3
Results: 8
1
2
RAPID REPORTER.
- Published in:
- Oncology (08909091), 2023, v. 37, n. 3, p. 146
- Publication type:
- Article
3
Evaluating Treatment Options and the Multidisciplinary Care of Ocular Toxicities of MEK Inhibitors.
- Published in:
- Oncology (08909091), 2023, v. 37, n. 3, p. 138, doi. 10.46883/2023.25920990
- By:
- Publication type:
- Article
4
Ocular Toxicities of MEK Inhibitors in Patients With Cancer: A Systematic Review and Meta-analysis.
- Published in:
- Oncology (08909091), 2023, v. 37, n. 3, p. 130, doi. 10.46883/2023.25920987
- By:
- Publication type:
- Article
5
Signaling Pathways in the Relapse of Glioblastoma.
- Published in:
- Oncology (08909091), 2023, v. 37, n. 3, p. 107, doi. 10.46883/2023.25920986
- By:
- Publication type:
- Article
6
Racial and Ethnic Disparities in Opioid Use Across the Cancer Continuum.
- Published in:
- Oncology (08909091), 2023, v. 37, n. 3, p. 102
- By:
- Publication type:
- Article
7
OUR KEY OPINION LEADERS HAVE BEEN BUSY! TAKE A LOOK TO SEE WHAT HAVE BEEN UP TO.
- Published in:
- Oncology (08909091), 2023, v. 37, n. 3, p. 95
- By:
- Publication type:
- Article
8
Updated Data and Groundbreaking Research Lead to an Exciting 2023 ASCO GI.
- Published in:
- Oncology (08909091), 2023, v. 37, n. 3, p. 96
- By:
- Publication type:
- Article